New podcast episode: The ACORD Collaboration: Innovative Clinical Trials for Neurodegenerative Diseases
30 Jun 2026
The UCL Innovative Clinical Trials Unit (formerly the MRC Clinical Trials Unit at UCL) has released a new episode of the Trial Talk podcast, marking the start of a new series for 2026.
ACORD is a pioneering collaboration that brings together experts from a wide range of disciplines to accelerate the development of treatments for neurodegenerative diseases.
In this episode, we explore how ACORD works in practice, the innovative methodologies that underpin it, including the multi-arm, multi-stage trial design, and the opportunities it creates for researchers at different stages of their careers. We speak with James Carpenter, one of ACORD’s founders, and Ed Jabbari, an ACORD Fellow, about the vision behind the collaboration, its potential to transform clinical research in neurodegenerative diseases, and how it has shaped Ed’s career journey.
The Trial Talk podcast is hosted and produced by Berta Terre-Torras, Science Communications Officer. Charlotte Harley, former Science Communications Officer, co-hosted and produced previous episodes.
For questions or feedback on the series, message us on BlueSky, LinkedIn, or send us an email.
If you enjoy these episodes, don’t forget to subscribe to our SoundCloud channel for more content (click the “Follow” icon).
Further information: